about
Survival of patients with oral cavity cancer in GermanyImpact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review.Population-based hormone receptor-specific incidence trends of breast cancer in Germany.The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.Normative data of the EORTC QLQ-C30 for the German population: a population-based survey[Collection and processing of personal data to evaluate cancer screening programmes - results of a survey of the German population in light of the bill 'early detection of cancer and cancer registries'].Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends.[The Health-Related Quality of Life as Measured with the SF-12v1 in Elderly People Living in Luebeck 2010/11 in Comparison with the German Norm Data in 1994].The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-upAntenatal care in singleton pregnancies after ICSI as compared to spontaneous conception: data from a prospective controlled cohort study in Germany.[Limitations of Social Participation in General Population - Normative Data of the IMET based on a Population-Based Survey in Northern Germany].[Lung cancer incidence and mortality: current trends and projections based on data from Schleswig-Holstein].Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.Imaging studies for the early detection of breast cancerMeasuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P)[Population-based incidence rates of colorectal neoplasms (2000 - 2006) - has systematic colonoscopy screening an impact on incidence? A combined analysis of cancer registry data of the Federal States of Bremen, Hamburg, Saarland and Schleswig-HolstAssessing health-related quality of life in urology - a survey of 4500 German urologistsPatients and Methods of the PATH Biobank - A Resource for Breast Cancer ResearchImputation of missing values of tumour stage in population-based cancer registrationProjection of Morbidity 2030 and 2050: Impact for the National Health System and Blood Supply.Recent Trends in Breast Cancer Incidence and Mortality in Germany.Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage.Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany.Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.Survival from colorectal cancer in Germany in the early 21st century.Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany.Predictors of Participation of Sophomore Medical Students in a Health-Promoting Intervention: An Observational Study.Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS).Beyond mammography screening: quality assurance in breast cancer diagnosis (The QuaMaDi Project).Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer RegistriesDeclining Bowel Cancer Incidence and Mortality in GermanyTrends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century.The population-based oncological health care study OVIS - recruitment of the patients and analysis of the non-participants.Different aspects of self-reported quality of life in 450 german melanoma survivors.Guideline-compatible treatment of breast cancer patients: the status quo in schleswig-holsteinEpidemiology of Breast Cancer - Current Figures and TrendsBisphosphonates and their Role in Therapy for Breast Cancer - Results from the PATH Biobank.Trends in hormone therapy and breast cancer incidence - results from the German Network of Cancer Registries.A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.
P50
Q21089823-9C49E274-5B8C-4578-A07A-2C5E1C45EFF7Q30244850-D2630500-2C76-4694-BCBD-4F845AB58262Q30318030-3F9EE2DE-0BC2-4827-B37F-67E6FAA60E5AQ30641961-13057821-75C8-4C6C-AA4D-DDDF1802C031Q30668968-AB275681-C130-4F39-84CF-0BF843AEA33EQ30680876-AA66BB58-ACF3-494E-BCB7-D1C31821EA0EQ30810370-A2199EA5-5E8C-4586-AC8F-EF5E79C76407Q30864728-1E24399B-7EA1-4086-BC99-1C92093D0692Q30993896-DB0E2974-3C8A-42FE-AE13-EF3270BD911FQ31020991-5332C67A-7C71-4350-969A-8E86AF4A4436Q31032525-A7EF34D5-C4AA-4216-96E2-E177B762703DQ33348706-98564443-533A-461C-8832-A2098ABA7CDCQ33424483-CBFDD842-A3AB-4954-905F-604364B23B09Q33480984-73CF5E87-8681-4C87-94BB-662AAFE459E3Q33495763-DCD4AF51-6D19-4176-AC1C-2A4B254B364FQ33761521-3145B57D-C9ED-42BB-9C9D-24EA167B4160Q33815022-AF1F30C4-F451-4219-BB13-E4D2D4C3D42CQ33832256-53B1F831-7942-4AC9-A495-644E74DD1F31Q34022295-FAE02665-98BF-4F2C-ADBF-E7F16CBFC37EQ34038238-49C94D63-C132-4A65-BE00-11B8BC6839E5Q34096113-D472F376-16E6-456D-B4E9-7B363F1F4ACDQ34212950-8A29BE41-C51F-4AE7-9359-0E50A7E8FC6DQ34826751-94082EEC-1CF2-46CA-81E8-C1905B135FB7Q35835086-B7D2BF8A-DB40-4D92-8A82-B37DBA15A49EQ35998420-3BDEF053-F8E2-44F2-B13B-5B644351C52BQ36123154-7A87FB34-D201-4E68-886B-4C86B49AC261Q36187063-3A898D3C-F15B-48B6-9EB1-28CA79E3DF8BQ36220133-B96D3E72-F7D2-4D0C-BA85-C61854621CE7Q36460501-A071F288-125D-4D62-B47C-4D93BAC37F92Q36610502-323CA21D-7213-460D-84DD-CBA673039C36Q36611288-15BE48A5-7B15-47C7-9FF8-220B8D6B87F8Q36686353-E6CF4CDC-9C89-4FB0-9F07-2DBA5746A4B6Q36714741-68F3DE44-05C7-4E0F-B23F-C0588F1606BFQ36976571-2891A4BF-8DDC-4AE4-98AA-0111B7313751Q37132768-B55115C9-6718-45DC-97EA-2202801C79B9Q37254736-22A06F29-8074-4EA8-A992-2A4CD148BCF3Q37382844-33F8171F-3968-4B9E-A4D7-73FAFDDE613DQ37395467-3369BC76-8B65-4435-BD1C-159FB429C1D2Q37444557-9324DF5A-0B16-4B58-A550-F2429EF2FF42Q37482598-675B34B3-6895-4A3E-B171-B17CFF5410E7
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Alexander Katalinic
@ast
Alexander Katalinic
@de
Alexander Katalinic
@en
Alexander Katalinic
@es
Alexander Katalinic
@nl
Alexander Katalinic
@sl
type
label
Alexander Katalinic
@ast
Alexander Katalinic
@de
Alexander Katalinic
@en
Alexander Katalinic
@es
Alexander Katalinic
@nl
Alexander Katalinic
@sl
prefLabel
Alexander Katalinic
@ast
Alexander Katalinic
@de
Alexander Katalinic
@en
Alexander Katalinic
@es
Alexander Katalinic
@nl
Alexander Katalinic
@sl
P227
P101
P106
P21
P214
4150565628006252699
P227
1139657860
P31
P496
0000-0003-0490-1554
P735
P7859
viaf-4150565628006252699